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Abstract
Brucellosis represents a serious health threat to human populations living in areas
endemic for the disease. The clinical manifestations of brucellosis are protean and non-
specific, and laboratory confirmation of the diagnosis is crucial for an adequate
management of the patient and implementation of infection control measures aimed
to control the disease in affected herds. Although brucellosis can be confirmed by
serologic tests and nucleic acid amplification assays, culture detection of circulating
Brucella organisms remains a diagnostic cornerstone. Traditionally, prolonged
incubation of media and performance of blind subcultures of negative blood culture
vials have been recommended to maximize isolation of the organism. In recent years,
modern automated blood culture systems have revolutionized the diagnosis of
human brucellosis by improving sensitivity and enabling detection of brucellae within
the routine one-week incubation protocol followed in most Clinical Microbiology
laboratories. Development of molecular techniques and mass-spectrometry technol‐
ogy have also shortened the time needed to identify members of the genus, whereas
use of biological safety cabinets considerably reduce the risks of contagion to
laboratory personnel.
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1. Introduction
Because of the non-specific clinical manifestations of human brucellosis and the need for
prolonged combination therapy with antibiotics that are not routinely prescribed for other
infectious diseases, laboratory confirmation of the diagnosis is of paramount importance for
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the adequate patient management. In addition, evidence of brucellosis has serious public
health implications because it discloses exposure to a contaminated source (infected animals
or their products, unsafe laboratory practices, or a potential biological warfare attack).
The current laboratory diagnosis of human brucellosis is based on culture, serology, and
nucleic acid amplification assays. Although the culture strategy is hampered by the slow
growing features of Brucella species, safety problems, and the reduced sensitivity of the method
for detecting chronic cases, isolation of the organism remains a diagnostic cornerstone.
Recovery of the brucellae is an irrefutable evidence of the disease; it permits speciation and
typing of the recovered strain for epidemiological studies [1] and enables determination of
antibiotic susceptibility, when indicated. Blood cultures may also allow diagnosis of brucel‐
losis in the acute period of the disease, when serological test results may still be negative or
exhibit borderline antibody titers [2]. An additional advantage of the culture approach is the
fact that it enables the diagnosis in cases in which brucellosis is not suspected. This is an
important consideration because the clinical presentation of human brucellosis is frequently
not specific, and patients may present with symptoms and signs suggestive of other diagnoses,
including a variety of infections, rheumatic, hematologic, or neurologic conditions, hepatitis,
etc. If the possibility of brucellosis is not considered, specific serologic tests or nucleic acid
amplification assays will not be ordered and, under these circumstances, the diagnosis of the
disease can be missed altogether, unless a positive blood culture was obtained. Isolation of
Brucella organisms can be, then, the first and only proof of the disease. For instance, in a study
conducted in a highly endemic area for B. melitensis in southern Israel, 27 blood cultures
obtained from 21 patients with suspected brucellosis grew the organism, as did 42 cultures
drawn from 27 patients in whom possibility of the disease was not entertained [3].
The current prevalence of brucellosis in most Western countries is low and, therefore, micro‐
biology laboratories are frequently unfamiliar with the tools available for isolating the
organism. The purpose of this review is to summarize published information on the perform‐
ance of the different blood culture techniques for the detection of brucellae. Because anaerobic
conditions do not support growth of the strictly aerobic members of the genus, only data on
the performance of aerobic media will be included in the chapter.
1.1. Role of blood cultures in the diagnosis of human brucellosis
Brucellosis is a systemic infection in which the bacterium initially localizes in the regional
lymph nodes and then disseminates by the hematogenous route to macrophages-rich tissues
where it adopts an intracellular lifestyle [4]. In the early stages of the disease, patients experi‐
ence continuous brucellemia, facilitating the culture diagnosis of the disease. As the infection
progresses, bacteremia tends to wane, making the recovery of the organism increasingly
difficult [5]. However, Brucella organisms may reappear in the bloodstream intermittently [5],
and their isolation is associated with an increased risk of relapse, probably because a demon‐
strable bacteremia implies a high bacterial burden [6, 7]. Even in localized infections, the
pathogenesis of brucellosis in the human host always implies a bacteremic phase and,
therefore, blood cultures may represent an adequate tool for establishing the diagnosis,
although their sensitivity varies widely (between 10% and 90%) in different series [5].
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2. Blood culture methods
The sensitivity of blood cultures for detecting circulating brucellae may be negatively influ‐
enced by a variety of factors such as patient’s age [8], prolonged or chronic clinical course [9–
12], or previous exposure to antibiotics [12, 13], as well as technical aspects including blood
sample volume, incubation time, frequency of growth monitoring, or the performance of blood
culture media and detection systems. Despite these drawbacks, blood culture techniques have
also been adopted for the isolation of Brucella spp. from normally sterile specimens other than
blood [14], such as bone marrow [12, 15, 16], synovial fluid aspirates [17], pancreatic exudate
[18], or cerebrospinal fluid [19], and have been shown to be comparable or more sensitive than
conventional culture methods on solid media.
2.1. Manual monophasic methods
Although Brucella organisms may be recovered by routine bacteriological culture methods,
detection of the organism in clinical specimens is frequently hindered by its slow growth.
Because seemingly negative blood culture vials are routinely discarded after a one-week
incubation period, unless physicians and laboratory personnel are aware of the possibility of
brucellosis, the diagnosis may be missed altogether. To maximize the detection of fastidious
members of the genus, incubation of blood cultures for 30 days and performance of blind
subcultures have been advised [20, 21]. This approach has obvious drawbacks: it is labor
intensive, prolonged incubation of blood culture vials requires large laboratory space and
costly equipment, and diagnosis of the disease is substantially delayed.
2.2. Biphasic methods
To circumvent the necessity of making repeat subcultures, an ingenious biphasic flask,
containing solid agar and a liquid phase, was developed by Ruiz-Castañeda in the late 1940s
[11, 14, 21, 22]. After inoculation, the flask is supplemented with 10% CO2 and tilted so that
the liquid covers the solid medium and incubated in the upright position. Flasks are examined
every 3 days for the presence of colonies [14, 21, 22]. If no growth is observed, flasks are tilted
again and re-incubated, and the cycle is repeated for at least 35 days [14, 21, 22].
Gotuzzo et al. reported their experience with the Castañeda method in Peru and observed that
brucellae colonies developed within one week, with a mean time-to-detection of 4.3 days when
seeded with bone marrow specimens, and 6.7 days when inoculated with peripheral blood,
and all positive results were obtained within 15 days of incubation [10]. In a Spanish study,
however, the time-to-detection was more prolonged, and the majority of flasks required
between one and three weeks of incubation [23]. Differences in the patients’ population, the
biological characteristics of the Brucella strains, or the composition and quality of homemade
media may explain the observed discrepancies in the performance of the method.
The capability of a commercial biphasic blood culture flask (Hémoline biphasic medium,
bioMérieux, Marcy l’Etoile, France) to recover Brucella melitensis was prospectively assessed
by Ruiz et al. [24]. Flasks were inoculated with 10 ml of blood obtained from patients with
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suspected brucellosis, incubated for three weeks, and subjected to blind subcultures on day
21. Although the median time-to-positivity was 5 days only, four out of 19 (21.1%) positive
cultures were detected after 7 to 9 incubation days [24].
2.3. Lysis centrifugation: In-house and commercial methods
Braun and Kelsh developed a membrane filter technique for isolating Brucella spp. and
evaluated its performance in a rabbit animal model [25]. A heparinized blood specimen
obtained from animals experimentally inoculated with Brucella organisms was subjected to
osmotic lysis and filtered through a sterile Millipore filter under negative pressure. Filters were
placed on the surface of solid media and incubated, and organisms trapped in the membrane
developed as colonies on the agar. The technique was abandoned because it was too cumber‐
some, time and labor intensive, and filters became easily plugged with cellular components of
the blood.
A new and original method was subsequently developed in which blood cells were osmotically
lysed, and this step was followed by centrifugation and spread of the lysate on the surface of
solid culture media [26, 27]. In 1984, Etemadi et al. evaluated this lysis centrifugation procedure
—also known as lysis concentration—and compared its performance with that of the Casta‐
ñeda flask for the detection of B. melitensis from blood and other normally sterile body fluids
[26]. All cultures, including 14 peripheral blood samples, two bone marrow, and two cerebro‐
spinal fluid specimens, were positive by the lysis centrifugation method within 48 hours,
whereas all 18 Castañeda flasks remained negative after 21 days of incubation [26].
A similar lysis centrifugation method was used by Mantur and Mangalgi who compared it
with the biphasic Castañeda vial in patients with acute and chronic brucellosis confirmed by
a standard agglutination test (SAT) titer ≥160 [28]. Of 121 patients with acute brucellosis, the
Castañeda method identified 87 (71.8%), whereas the lysis centrifugation was positive in 110
(90.9%) patients (P=0.001), and the time-to-detection was 6.7±2.2 and 2.4±0.9 days, respectively
(P<0.001). Of the 27 patients with chronic disease, the detection rates were 3.3% (n=9) for the
Castañeda flask and 74.1% (n=20) for the lysis centrifugation method (P=0.087), and the time-
to-detection was 7.2±2.6 and 2.7±1.4 days, respectively (P=0.001). In a more recent study, the
lysis centrifugation recovered B. melitensis in 73 (43.1%) of 169 serologically-confirmed human
cases, compared to 42 (24.8%) detected by the blood clot culture and 59 (34.9%) by the
Castañeda technique, and the detection time was significantly shorter [29].
Encouraging results were also obtained in Peru by Espinosa et al. who compared the per‐
formance of the traditional Castañeda method with that of Etemadi’s lysis centrifugation
technique in 88 patients in which the disease was suspected on the bases of compatible clinical
symptoms and a SAT titer ≥1:25 [9]. The two methods were similar in terms of sensitivity: the
lysis centrifugation procedure detected Brucella organisms in 38 (43.2%) patients while the
Castañeda flask succeeded in 31 (35.2%) patients (P>0.05). However, the detection times
differed significantly and were 3.8±0.8 days for the lysis centrifugation and 13.6±6.5 days for
the Castañeda method (P<0.001). In a prospective study, Kolman et al. obtained blood cultures
from Israeli patients with serologically proven brucellosis [27]. Blood sample aliquots were
subjected to an in-house lysis centrifugation procedure and inoculated into an aerobic
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radiometric BACTEC system (Becton Dickinson Diagnostic Instrument Systems, Towson, Md.,
USA) vial [27]. The lysis centrifugation detected B. melitensis in only 15 (27.8%) out of 54
patients, whereas the comparator succeeded in 19 (35.2%) patients. The lysis centrifugation
method, however, detected brucellae after an average of 3.5 days (range 2–4 days) vs.14 days
(range 7–30 days) by the automated system.
The traditional in-house lysis concentration methods have been replaced in recent decades by
a commercial blood culture system (the Isolator Microbial Tube, Wampole Laboratories,
Cranbury, NJ, USA). Collected blood samples are inoculated into a vial containing a mixture
of the anticoagulant sodium polyethol sulfonate (SPS) and detergent. The detergent lyses the
blood cells releasing already phagocytized but still viable organisms, and the lysate is then
seeded onto appropriate solid media and incubated. The system has two versions: a small tube
for use in pediatric patients that accommodate up to 1.5 ml of blood and, therefore, is plated
directly; and a larger 10 ml-containing tube for use in adult patients that require a preliminary
centrifugation step to concentrate the lysate before plating.
In a prospective study, Navas et al. inoculated 10 ml of blood obtained from patients with
presumptive brucellosis into an Isolator Microbial Tube, and two 5 ml-aliquots were inoculated
into one aerobic (NR6A) and one anaerobic (NR7A) BACTEC NR660 vials [30]. The two
methods were comparable in terms of sensitivity, the Isolator Microbial Tube detected 7
positive cultures system vs. 6 identified by the automated system. [30]. The lysis concentration
technique reduced the time-to-detection to 2–5 days vs.17 to 29 days with a mean of 20.6 days
for the BACTEC blood culture system. It should be noted, however, that because anaerobic
bottles do not support the growth of strictly aerobic Brucella organisms, the effective blood
volume inoculated into the BACTEC system was, in fact, only half of that seeded onto the
Isolator Microbial Tube plates [30].
A study conducted in a region endemic for B. melitensis in Israel confirmed the capability of
the Isolator Microbial Tube system to accelerate the detection of the organism as compared to
traditional methods, and 15 out of 22 (68.2%) blood cultures were already positive after 72
hours [31]. When compared with the automated BACTEC 9240 system, however, the Isolator
Microbial Tube was inferior in terms of both time-to-detection and sensitivity (see “Compa‐
rative studies involving fully automated blood culture systems” section).
2.4. Automated blood culture systems
In the past, detection of positive blood culture vials relied on periodic examination of inocu‐
lated vials for the presence of turbidity as an indication that microorganisms have multiplied
in the broth and reached a high concentration. Over the last few decades, the diagnosis of
bacteremic infections has been revolutionized by the development of automated blood culture
systems. The novel technologies are based on detections of increasing concentrations of CO2
released by the metabolic activity of a growing mass of organisms, or consumption of the
available oxygen. Significant changes in the gas content of the blood culture vials can be
detected before cloudiness becomes visible, resulting in the gain of precious time and allowing
early diagnosis of bacteremia. The detecting technology evolved over the years; the pioneer
semi-automated BACTEC 460 detected release of radioactive CO2 generated by the metabolism
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of 14C-containing substrates by penetrating the vial top and aspirating the headspace above
the fluid level. The subsequent generations consisted of fully-automated instruments that
employed either detection of CO2 levels by invasive infrared reading (BACTEC NR), non-
invasive measurement of increasing fluorescence as the concentration of CO2 increases or the
O2 content decreases (the BACTEC 9000 and FX series of instruments), colorimetric CO2
measurement (BacT/ALERT, bioMérieux, Marcy l’Etoile, France), or quenching of fluorescence
by CO2 production and acidification or reduction of the culture broth (VITAL, bioMérieux,
Marcy l’Etoile, France). Overall, published studies indicate that technical advances in the
detection technologies and improvements in the composition of broth culture media have
resulted in gradual increase in sensitivity, shortened time-to-detection of Brucella organisms,
enabling labor saving by continuous hands-off monitoring of a large number of blood culture
vials and decrease in culture contamination rates.
Experience with the isolation of Brucella spp. by automated blood culture systems has been
accumulating at a slow pace. Although the disease is still prevalent in many developing
countries, use of modern bacteriologic techniques in endemic areas is limited because of their
high cost, whereas in the more affluent Western world, where use of modern automated
systems is widespread, brucellosis has been successfully controlled or eradicated altogether.
2.5. Factors influencing detection of brucellae by automated systems
In general terms, detection of CO2 production in blood culture broths depends on the initial
number of bacteria inoculated (which reflects the concentration of circulating organisms and
the volume of the blood sample drawn), duplication time of the species, its intrinsic metabolic
activity, composition of the media, presence of growth promoters or inhibitory factors,
frequency of readings, sensitivity of the sensor, and threshold levels.
Obviously, obtaining a large blood specimen should improve the sensitivity of the blood
culture tool for detecting bacteremia. In practice, the volume of blood inoculated in the bottle
varies little (usually between 1 to 3 ml per bottle in children and 3 to 5 ml in adults) because
of the requirement to keep at least a 1:5 to 1:10 blood-to-broth ratio to reduce the concentration
of detrimental factors such as complement, antibodies, or antibiotics contained in the clinical
specimen.
The magnitude of Brucella bacteremia is frequently low with a median of 88 CFU/ml [31, 32]
and a range of 1.3 CFU/ml to >1,000 CFU/ml in children [31]. As it should be expected, the
time-to-positivity of automated blood culture systems correlates inversely with the concen‐
tration of circulating organisms, validating the results of experimental studies with simulated
blood cultures [33, 34]. In addition, Brucella organisms have a relatively long (2.5 to 3.5 hours)
doubling time compared to other pathogenic bacteria [32]. This feature, coupled with the low
CO2 production by members of the genus, results in delayed detection of brucellae by some
automated blood culture systems. In a series of in vitro studies using the BacT/ALERT system,
a slow release of CO2 by B. melitensis compared with other human pathogens was observed,
and the peak concentrations of the gas were inferior [33]. In a series of experiments with
BACTEC NR730 vials inoculated with brucellae, Gamazo et al. reported that noticeable
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turbidity was noted in the vial on average 24 hours earlier than detection by the automated
instrument [32].
With the purpose of improving CO2 production by Brucella organisms, the effect of adding a
variety of supplements (pyruvate, alanine, glutarate, urea, glucose, and erythritol), as well as
changing the pH of the culture broth was investigated [32]. Only alanine and pyruvate resulted
in a mild increase in the CO2 production, while lowering the pH of the medium from 7.2 to 6.2
coupled with pyruvate supplementation, induced a more pronounced increment. Although
these experimental results suggest that modifications in the formulation of blood culture media
may reduce the time-to-detection of Brucella bacteremia, changes in the broth composition may
not necessarily sustain growth of other bacterial species. In the same study, a harmful effect
of the anticoagulant SPS contained in the blood culture vials was demonstrated. Unfortunately,
blood culture systems cannot dispense with the use of SPS because there are no good alterna‐
tives to the antiphagocytic, anticomplementary, and aminoglycoside-neutralizing effects of
this compound. In the vials of the 9000 series of BACTEC instruments, the concentration of
SPS has been reduced to 0.025% compared with 0.035% in the NR660 and BacT/ALERT media
and the total volume of broth has been increased from 30 ml in the NR660 system to 40 ml in
the BACTEC 9000 instruments vials, improvements that may explain the better performance
of the latter systems for detecting fastidious Brucella organisms [35].
2.6. Radiometric detection of brucellae
The BACTEC 460, developed in the early 1970s was the first in a series of modern blood culture
systems. Published experience with the use of this method for the recovery of brucellae from
blood is limited and obtained results were suboptimal [27, 36–38]. In 1984, Arnow et al.
investigated a cluster of foodborne B. melitensis infections among travelers to endemic Spain
[36]. Overall, 15 out of 19 (78.9%) blood cultures derived from 6 patients were detected by the
automated instrument between 4 and 8 days of incubation. In another report, brucellae were
only recovered from a blind subculture performed in a three-day-old vial that remained
radiometrically negative despite having been incubated for 6 additional days [37].
In a comparative study, Serrano et al. obtained 83 blood culture sets from 42 patients with
positive Brucella agglutinin titers [38]. Five ml of blood were inoculated into an aerobic
BACTEC 460 vial and an identical volume was inoculated into a Castañeda flask, incubated
for 10 days, and subjected to blind subcultures on days 5 and 10. By day 5, 14 cultures were
positive. The Castañeda method detected 12 positive cultures (85.7%) and the BACTEC bottle
10 (71.4%), of which only 2 were detected radiometrically and the remaining by subculture
only. On day 10, 49 cultures were already positive by the biphasic flask and 56 by the radio‐
metric medium (P>0.05), of which only 27 reached the radiometric positivity threshold [38].
2.7. Infrared detection system
Data on the use of infrared detection technology (BACTEC NR instruments) for the detection
of Brucella spp. are also scarce [3, 27, 30, 34, 39, 40]. Zimmerman et al. recovered B. abortus by
subculture of two five-day-old blood cultures and from a seven-day-old bone marrow culture
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inoculated into aerobic BACTEC NR vials [34]. Once the diagnosis was made, additional blood
cultures were obtained and 15 vials, including aerobic, osmotically stabilized (aerobic hyper‐
tonic), and anaerobic media were inoculated and monitored by the automated instrument. All
five aerobic and four osmotically stabilized vials became positive between 7 and 20 days,
whereas, as expected, all five anaerobic bottles remained negative.
In a Spanish study, inoculated BACTEC NR vials and biphasic Hémoline flasks were moni‐
tored for three weeks, and negative media were blindly subcultured on day 21. The biphasic
system detected 28 positive cultures, obtained from 18 patients, after an average of 7 days. The
BACTEC NR system detected only 12 positive bottles, missed 10 patients, and the mean time-
to-positivity was substantially longer (19.6 days) [39]. Furthermore, 11 of these 12 BACTEC
NR positive vials gave negative infrared readings during the three-week incubation period,
and the organism was detected by subculture only [39].
In the aforementioned study by Navas et al., the BACTEC NR instrument detected only 12 out
of 16 (75.0%) blood culture sets obtained from 7 patients and missed the diagnosis in 1 patient,
whereas the Isolator Microbial Tube detected all 7 patients, and the time-to-positivity was
significantly shorter [30]. Employing the BACTEC NR system, Gedikoglu isolated brucellae
in 22 patients with a median detection time of 72 hours [40]. Because vials were only kept for
7 days and no blind subcultures of negative bottles were performed, the study does not allow
assessment of the sensitivity of the system for detecting brucellae within the routine one-week
incubation protocol.
To assess the capability of the BACTEC NR blood culture system to detect B. melitensis within
the conventional one-week incubation schedule, we conducted a prospective study in southern
Israel [3]. Blood culture vials were monitored by the automated instrument and subcultured
once a week for four weeks, and the proportion of positive cultures detected by the instrument
within the first week was determined. During the two-year study period, 27 of 373 (7.2%) blood
cultures, drawn from 21 patients, were positive for brucellae. Twenty-one (78.8%) of these
cultures were detected by the BACTEC NR instrument within 7 days, and 6 positive cultures
(22.2%) were detected by subculture after two or three weeks, corroborating that prolonged
incubation and periodic performance of subcultures of negative bottles were still required to
optimize the detection of B. melitensis by the non-radiometric BACTEC technology.
2.8. Continuous monitoring systems
BacT/ALERT system. The published experience with the use of the BacT/ALERT system for the
recovery of circulating brucellae remains limited [18, 33, 41]. In 1992, Solomon and Jackson
isolated B. melitensis in a traveler to the Middle East after only 2.8 days [33]. Two years later,
Casas et al. drew blood cultures from 6 patients with serologically-confirmed infection [41].
Inoculated bottles were monitored by the BacT/ALERT instrument for 10 consecutive days and
were then transferred to a regular incubator for 10 additional days, and blind subcultures on
solid media were performed on days 10 and 20. Only 1 of 9 positive bottles was detected by
the automated instrument after 2.9 days, while the remaining bottles were detected by
subculture only: 7 on day 10, and 1 on day 20 [41]. A different experience was reported by Roiz
et al. who found that all 9 blood cultures, obtained from 5 patients, yielded the organism within
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3.7 days, and a blood culture vial, inoculated with pancreatic fluid, was detected positive after
13.3 hours only [18].
BACTEC 9000 instruments. In 1996, Gedikoglu et al. summarized the experience accumulated
in a Turkish hospital with the use of the BACTEC 9120 system with a one-week monitoring
protocol [40]. Thirty blood cultures, drawn from 15 patients grew B. melitensis within 84 hours
of incubation. Akcam et al. compared the BACTEC 9120 blood culture system and conventional
cultures for culturing normally-sterile body fluids other than blood employing the aerobic
pediatric vial and a 7-day incubation protocol, and reported that the five clinical specimens
containing B. melitensis were only detected by the automated instrument [14].
Kurtoglu et al. summarized the experience accumulated with the BACTEC small 9050
instrument and the medium-size 9120 model for culturing blood in an endemic area for
brucellosis in Turkey. The study employed a routine 5-day protocol but extended the incuba‐
tion period to 14 days when brucellosis was suspected [42]. All brucellae were recovered within
10 days but no precise information on the time-to-positivity was reported, and the fraction of
organisms detected within the routine protocol’s timetable was not stated. Using the BACTEC
9240, a larger version of the system, and a similar incubation protocol, we detected 59 of 77
(76.6%) positive Brucella cultures within 4 days (unpublished data).
Despite these encouraging results, limiting incubation of blood culture vials to the traditional
one-week period instituted in most clinical laboratories cannot be adopted in regions endemic
for brucellosis, unless it is convincingly demonstrated that no significant number of positive
cultures are missed by a short incubation schedule. Adequate assessment of the capability of
any blood culture system to detect brucellae within the routine one-week incubation protocol
requires keeping of inoculated vials for a longer period and performance of blind subculture
of negative vials to assure that no positive cultures are overlooked.
The capability of the BACTEC blood culture system to detect brucellae within 7 days was
prospectively investigated among febrile children in southern Israel [43]. Following the
traditional recommendations by the World Health Organization [20] and the American Society
for Microbiology [21], inoculated aerobic pediatric blood culture vials were monitored by the
BACTEC 9240 instrument for four consecutive weeks, and blind subcultures of negative vials
were performed once a week [43]. Of a total of 2,579 blood cultures drawn, 42 (1.6%) were
positive for B. melitensis, of which 41 (97.6%) were detected by the automated instrument within
2 to 6 days, and the remaining positive vial was missed by the instrument and detected by
blind subculture performed on day 7. Cumulative positivity rates by the automated detection
were 0.0%, 23.6%, 78.9%, 86.8%, 92.1%, 97.6%, and 97.6% for days 1 through 7, respectively.
Similar results were obtained in a study conducted in Saudi Arabia in a mixed population of
children and adult patients [35]. BACTEC 9240 aerobic/F (for adults) and Peds Plus vials (used
for pediatric patients) were kept for up to 21 days, but no blind subcultures of negative vials
were performed, precluding an adequate assessment of the sensitivity of the method. Overall,
the BACTEC instrument detected 90 out of 97 (92.7%) positive cultures, of which 85 yielded
B. melitensis and 12 B. abortus isolates within 5 days of incubation, and only 3 cultures (3.1%)
became positive after the seventh day (2 on day 8 and 1 on day 9) [35].
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Durmaz et al. reviewed their five-year experience with the BACTEC 9120 system in a Turkish
hospital [44]. Vials were monitored by the automated instrument for 7 days and vials negative
at the end of period were Gram-stained and subcultured. Overall, 20 vials yielded B. meliten‐
sis after a median 69.9 hours (mean: 30.0 hours, range: 31.2–117.5 hours), and no false negative
automated readings were recorded.
However, in another Turkish study, 8 of 136 cultures obtained from 60 patients, remained
undetected by the instrument and were recovered on blind subcultures performed after 30
days of incubation [45]. A similar experience was recorded in the investigation of an outbreak
of B. melitensis infections involving 16 adult Spanish patients [46]. The researchers employed
the BACTEC 9050 that differs from the other instruments of the BACTEC 9000 series in that
agitation of the bottles is continuous, a factor that may accelerate bacterial growth, whereas in
the other models is intermittent. Inoculated bottles were incubated for 21 days, and negative
vials were subcultured blindly at the end of the study period [46]. Overall, 13 patients had
demonstrable Brucella bacteremia. Growth of the organism was detected by the instrument
within one week in only 9 (69.2%) bacteremic individuals, in 2 additional patients on the 8th
and 11th day, and in the remaining 2 patients, brucellae were entirely missed by the instrument
and detected by the final subculture.
Although the reasons for these discrepancies are not obvious, the superior performance of the
automated BACTEC system in the aforementioned communication by Yagupsky et al. [43]
could be explained by the fact that their study population consisted entirely of children
presenting to the Pediatric Emergency Department with an acute febrile disease, probably
characterized by continuous high-magnitude bacteremia, whereas other investigations
enrolled mostly adult patients with a more prolonged disease and, therefore, a lower bacterial
load.
The BACTEC MYCO/F LYTIC medium has been recently developed to improve the recovery
of intracellular pathogens such as fungi and mycobacteria by lysing leucocytes with saponin
[47]. Because brucellae are facultative intracellular bacteria, it was assumed that use of the
automated blood culture system coupled with this novel medium would improve both
sensitivity and time-to-detection of circulating organisms. However, in a prospective study in
which the performance of the traditional pediatric (Peds Plus /F) and adult (PlusAerobic/F)
aerobic vials were compared with that of the MYCO/F LYTIC vial, the sensitivity was com‐
parable but the time-to-positivity was significantly longer in the latter (101.4±46.7 hours) vs.
65.5±18.9 hours for the traditional media combined (P=0.004), and after 72 hours of incubation,
only 5 out of the 16 (31.2%) MYCO/F LYTIC vials were already positive, compared to 16 out
of 19 (84.2%) aerobic adult and pediatric vials (P=0.005).
2.9. Comparative studies involving fully automated blood culture systems
In a prospective study in which blood aliquots drawn from children with suspected brucellosis
were inoculated into a BACTEC 9240 aerobic vial and into an Isolator Microbial Tube, the
sensitivity and time-to-positivity of the two methods were compared [31]. Overall, 122 pairs
of blood cultures were obtained and 28 (22.8%) were positive by at least one method. The
BACTEC system detected all 28 positive cultures and the Isolator Microbial Tube detected 22
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positive cultures (sensitivity: 78.6%, P<0.023). Among those 22 cultures positive by both
methods, 21 (95.5%) and 15 (68.2%) were found to be positive within 3 days by the BACTEC
and by the lysis centrifugation systems, respectively. Eight cultures (36.4%) were detected at
least 1 day earlier by the BACTEC instrument, and the remaining 14 were detected by the two
systems on the same day (P<0.05). In summary, the automated BACTEC system was signifi‐
cantly superior than the compactor in terms of sensitivity and also reduced the time-to-
positivity.
The performance of the two most popular automated blood culture systems for the detection
of brucellae was compared in a single study [48]. BacT/ALERT and BACTEC 9,240 vials were
inoculated with 10 ml of adult patients’ blood and monitored for 7 days. Overall, the BACTEC
system detected 9 out of 17 (52.9%) positive cultures whereas the BacT/ALERT detected 14
(82.3%) (P=0.067), and the time-to-detection of the positive vials were similar (2.8 vs. 2.5 days,
respectively). Apparently, no blind subcultures of negative vials were performed, and it is
unknown whether a more prolonged incubation would have improved the recovery rate.
The performance of three blood culture systems [the automated BACTEC 9120 and VITAL
(bioMérieux) systems, and the Hémoline biphasic flask] was compared in a prospective study
involving 19 positive blood cultures drawn from Spanish patients with brucellosis [24]. The
Hémoline medium detected all 19 positive cultures, whereas the BACTEC and the VITAL
systems missed one positive culture each (sensitivity: 94.7%). By using a 5-day incubation
protocol, 47.4%, 78.9%, and 10.5% cultures were detected by the three blood culture systems,
respectively. When the incubation was extended to 7 days, the results were 73.7%, 94.7%, and
47.4%, respectively, indicating that the BACTEC system was significantly faster than the
comparators (P<0.05). The delayed detection of brucellae by the VITAL system was confirmed
in two later studies in which the time-to-positivity for members of the genus was 119.7 and
211.7 hours [49, 50].
2.10. Bone marrow vs. blood cultures
Because of the suboptimal recovery rate of brucellae from blood, it has been suggested that
cultures of bone marrow [14, 10, 11, 51, 52], liver tissue [53, 54], or lymph nodes [55] may
improve the recovery of the organism. The rationale for these alternative approaches is that
Brucella organisms survive the intracellular killing by phagocytes and polymorphonuclear
leukocytes and localize in the reticuloendothelial system [10, 52].
Ganado and Bannister demonstrated that in one-fifth of patients in whom bone marrow
cultures were positive for brucellae, the organism could not be isolated from the blood [39].
Gotuzzo et al. reported that among 50 patients with proven brucellosis detected by cultures
of blood, bone marrow, or both, bone marrow cultures were positive in 46 (92.0%) patients
whereas blood cultures were positive in only 35 (70.0%) [10]. Despite the small volume of bone
marrow cultured (usually less than 1 ml) compared to the much larger blood volumes (between
5 and 10 ml), brucellae grew more rapidly from bone marrow samples, suggesting that higher
bacterial concentrations may be present in this macrophages-rich specimen type. In a pro‐
spective study by Mantur et al., blood samples and bone marrow aspirates obtained from 103
Indian patients with serologically confirmed brucellosis were inoculated into Castañeda flasks
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[15]. The sensitivity of bone marrow cultures was significantly superior and recovered Brucella
organisms in 85 (82.5%) patients vs. 47 (45.6%) detected by blood cultures (P<0.001), and the
time-to-recovery was significantly shorter (2.8±0.7 and 7.2±2.4 days, respectively, P=0.001) [15].
It is noticeable that the superior performance of the bone marrow culture was observed in
acute, as well as in chronic cases.
Özkurt et al. obtained blood and bone marrow samples from 50 Turkish patients with
suspected brucellosis, of which 48 exhibited SAT titers ≥1:160 [12]. Specimens were inoculated
into BacT/ALERT vials and into a homemade Brucella broth medium. Seeded BacT/ALERT
vials were incubated for 7 days. Negative vials at day 7 were incubated for two additional
weeks and subcultured on solid media every 2 days. The non-commercial Brucella broth media
were incubated for four weeks and subcultured blindly every 2 days. The bone marrow
specimens proved to be more sensitive for the detection of B. melitensis and, overall, 35 of 50
(70.0%) bone marrow cultures, but only 24 of 50 (48.0%) blood cultures grew the organism
(P<0.05).
On the other hand, Magill and Killough found that in their experience, blood cultures were
more reliable (sensitivity: 90%) than bone marrow cultures (sensitivity: 40%) [56]. Similarly,
Shehabi et al. reported a sensitivity of 44.4% for blood cultures compared to 27.7% for bone
marrow cultures [57]; and Iseri et al., employing the BACTEC 9050 instrument, also found
peripheral blood cultures to be more sensitive than bone marrow aspirates [detection rates 39
out of 102 (48.0%) and 35 out of 102 (34.3%), respectively (P<0.05)] [16].
Although current evidence regarding the relative merits of bone marrow vs. peripheral blood
cultures remains controversial, most experts considered the former as the gold standard
specimen for diagnosis [4]. However, it should be pointed out that blood cultures have the
clear advantage of being easy to obtain and repeat, and the fact that they can serendipitously
identify cases in which the diagnosis was not entertained; whereas aspiration of bone marrow
samples for detecting brucellae requires, a priori, a high index of suspicion.
2.11. Blood clot cultures
Because the serum of patients with brucellosis may have antibacterial activity, culture of the
blood clot, where organisms phagocytized by leukocytes may be trapped, appears as a rational
strategy. The method consists of collecting a blood sample in a sterile tube and allowing it to
cloth. The tube is then centrifuged and the serum is separated aseptically and used for
serological assays, whereas the clot is disrupted by shaking the tube and seeded into appro‐
priate media [29]. Available data on the advantages of this technique, however, are limited
and contentious. Escamilla et al. employed two types of clot cultures, one with added tauro‐
cholate-streptokinase and the other with bile, and compared their yield with that of conven‐
tional cultures of whole blood in an area endemic for brucellosis in Peru and found the clot
cultures were far less sensitive and more labor-intensive than the comparator method [58].
Whereas the conventional cultures detected 28 of 30 (93.3%) positive cultures, the taurocholate-
streptokinase was positive in 21 (70.0%) and the bile-clot recovered the organism in a single
culture (3.3%). It is unclear whether culturing of the clot without the additives could have
provided better results.
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In a comparative study of 169 serologically confirmed patients, Mangalgi and Sajjan reported
a detection rate of 34.9% for the clot culture, 24.8% for the Castañeda flask, and 43.1% for the
lysis concentration method; the mean±SD recovery times were 5.8±1.4, 9.6±1.7, and 4.1±0.9
days, respectively [29]. In a second study by the same research group, blood clot cultures were
clearly superior to conventional broth cultures of whole blood for isolating brucellae, increas‐
ing the yield by >20% and shortening the time-to-positivity from an average of 8.2 days to 3.1
days [59]. If these favorable results are confirmed by additional research, this simple and
inexpensive method could represent a real contribution to the diagnosis of brucellosis in
developing countries where more advanced and expensive laboratory technologies are not
available.
3. From detection to identification
3.1. Conventional identification of blood culture isolates
Once bacterial growth is detected in a blood culture vial, prompt and precise identification of
the isolate is of paramount importance for adequate patient management and avoidance of
exposure of laboratory technicians to infective Brucella organisms. Traditionally, a Gram stain
of the positive broth is performed and, unless the biphasic Castañeda method is employed, it
is subcultured onto solid media. Identification of members of the genus Brucella is based of the
presence of typical small Gram-negative coccobacilli (see Figure 1); positive oxidase, catalase,
and urease tests; no fermentation of sugars; CO2 requirement; lack of motility; and confirmed
by a positive agglutination reaction with specific antiserum [14] or, alternatively, the iso‐
late’sbiochemical profile is determined by a commercial system. The main drawbacks of this
traditional approach is the slow turnaround time (2 to 3 days) and the possible misidentifica‐
tion of brucellae as Ochrobactrum anthropi [60], Ochrobactrum intermedium [61], Bergeyella
zoohelcum [62], or Moraxella phenylpyruvica by commercial kits; a serious mistake that has
already lead to an outbreak of laboratory-acquired infection [63].
Figure 1. Gram stain of a positive aerobic BACTEC blood culture vial showing Brucella melitensis microcolonies (white
arrows).
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3.2. Rapid phenotypic identification methods
A simple and rapid method was proposed by Rich and co-investigators in Saudi Arabia for
the presumptive identification of brucellae from signal-positive BACTEC 9240 blood culture
vials [64]. Thirty-three positive BACTEC broths containing Gram-negative coccobacilli and 32
with no visible organisms were subcultured on urea slants and incubated in a CO2-enriched
atmosphere. Of the 44 Brucella isolates eventually recovered, 37 gave a positive urease reaction
within 4 hours and the remaining were positive after overnight incubation. The urease test
showed good specificity and only 2 isolates other than brucellae (both Haemophilus influenzae)
gave a delayed positive urease reaction. Favorable results were also reported by Maleknejad
et al. in an endemic area of Iran using a slight modification of the procedure [65]. The inves‐
tigators combined the routine Gram staining procedure of positive vials with the high
sensitivity of the acridine orange staining, and inoculated positive media onto urea slants. The
procedure correctly identified the 41 blood cultures positive for brucellae within 4 hours and
was negative in 61 slants seeded with blood culture broths that grew other bacterial species.
In recent years, introduction of matrix-assisted laser desorption ionization-time of flight mass
spectrometry (MALDI-TOF) technology in the Clinical Microbiology laboratory has revolu‐
tionized the field of bacterial speciation, enabling precise, reproducible, and cost-effective
identification of isolates within minutes. The method obviates the need for biochemical testing
and, thus, is suitable for high-throughput by less skilled laboratory personnel [66, 67]. This
novel approach can be employed on bacterial colonies growing on agar plates, as well as from
positive culture broths and, therefore, it enables direct identification of organisms from blood
culture vials [68]. Available data with type strains and simulated blood cultures indicate that
the MALDI-TOF procedure reliably identifies isolates as members of the genus Brucella. It
should be pointed out that because of the high transmissibility of Brucella organisms, an initial
bacterial inactivation step with absolute ethanol was added as a measure of caution, to be
followed by extraction with formic acid and acetonitrile [69, 70]. Although in some studies,
the method also enabled discrimination at the species level and even at the biovar level for B.
suis [66, 67], other investigators reported unreliable discrimination between the different
Brucella species [68].
In summary, major advancements in spectrometry technology over the last decade have
opened the possibility of accurate and rapid identification of brucellae directly from blood
culture vials. Data on the use of MALDI-TOF method for this purpose, however, are still
limited because, although the cost for specimen processing is low, MALDI-TOF instruments
are expensive and, thus, unavailable in most resources-poor rural areas endemic for brucel‐
losis. Although experimental results are promising, this encouraging experience awaits
confirmation with real cultures derived from actual patients.
3.3. Identification of brucellae by DNA technology
A variety of molecular approaches have also been proposed to shorten the identification
process and enable correct identification of Brucella isolates. A fluorescence in-situ hybridiza‐
tion (FISH) assay targeting a part of the 16S rRNA gene and containing an unlabeled competitor
differing from the probe at one base with the purpose of preventing cross-binding, has been
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developed and evaluated with actual blood cultures [71]. The test was employed directly in
positive blood culture broths and enabled rapid and correct identification of B. melitensis at a
low cost, and was negative in cultures that grew a variety of other bacterial species.
Sequencing of the 16S rRNA gene, which is in widespread use for bacterial identification, can
be misleading and Brucella organisms cannot be accurately distinguished from the closely
related α-protobacterial Ochrobacterium species [72]. A novel recA gene-based, multi-primer,
single-target PCR assay has been recently developed and succeeded in differentiating between
brucellae and Ochrobacterium anthropi and O. intermedium [73], although the test has a more
prolonged turnaround time and is more expensive than the FISH test.
4. Blood cultures for brucellae and laboratory safety
Brucellosis remains among the most commonly recognized causes of laboratory-transmitted
infections, and 2% of all brucellosis cases are laboratory-acquired [74]. Several biological
characteristics make brucellae easily transmissible within the close confinement of the Clinical
Microbiology laboratory: the infecting dose for humans is very low (10 to 100 bacteria); the
organism may enter the body in many ways relevant to laboratory practices, including through
the respiratory mucosa, conjunctivae, gastrointestinal tract, or abraded skin [74]; and the long-
term persistence of viable microorganisms on inanimate surfaces [13, 75].
Because of the protean manifestations of brucellosis in humans, a wide array of clinical samples
submitted to the Clinical Microbiology laboratory for culture, including normally sterile body
fluids, exudates, and tissues, may contain viable bacteria, although blood cultures represent
the largest number of specimens. The concentration of circulating brucellae in the patients’
blood is frequently low [31], and unless a serious breach of safety practices has occurred, blood
specimens do not pose a tangible threat of contagion to laboratory personnel. In addition,
current automated blood culture instruments monitor CO2 production without penetrating
the blood culture vial and, thus, avoid creation of risky aerosols. However, the danger of
significant exposure increases exponentially after incubation, and routine bacteriologic
procedures such as preparing, centrifuging, and vortexing of bacterial suspensions, perform‐
ing subcultures and biochemical testing, particularly the catalase test, entail a substantial
potential for nebulization of bacteria, accidental spillage, and contamination of the laboratory
environment [76].
In regions endemic for brucellosis, the number of positive cultures for the organism and,
consequently, the risk for transmission to laboratory personnel can be extremely high. In a
Clinical Microbiology laboratory in Ankara, Turkey, an annual average of 400 cultures were
positive for Brucella spp. and the disease was diagnosed in 10 (18%) of 55 laboratory workers,
representing a calculated hazard of 8% per employee-year [77]. In a study conducted in 1997
at the Soroka University Medical Center (SUMC) that serves an endemic area for the disease
in southern Israel, 127 of 3,974 (3.2%) aerobic blood culture vials detected as positive by the
automated BACTEC instrument, as well as 11 of 126 (8.7%) Isolator Microbial Tube cultures,
grew B. melitensis [78]. From 2002–2009, the organism was isolated from 514 of 20,620 (2.5%)
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positive blood culture vials and, as expected, the detection rate showed a significant seasonal
pattern and was higher between April and September (3.3%) compared with the October-
March period (0.9%, P<0.001) [79].
To increase laboratory safety, the Centers for Disease Control (CDC) has strongly recom‐
mended that all manipulations with live Brucella cultures should be confined to a Class II
biologic safety cabinet [80]. However, by the time bacterial isolates are identified as brucellae,
extensive manipulation of culture media has usually been performed and inadvertent
exposure of laboratory personnel may have already occurred. Following a large outbreak of
laboratory-acquired brucellosis at the SUMC in 1997 [78], all positive blood cultures are
initially processed in safety cabinets until the presence of the organism is ruled-out, and
performance of unnecessary antibiotic susceptibility testing of Brucella isolates and aerosol-
generating procedures has been discontinued, and no further cases of the disease have been
detected ever since. It seems, then, prudent to recommend that all positive blood culture vials
in endemic areas should be processed in a safety cabinet, when available, pending final
identification of the isolate.
5. Conclusions
Although the diagnosis of human brucellosis can be established by serologic and nucleic acid
amplification assays, culture confirmation of the disease has not lost its traditional clinical and
epidemiological importance. In the past, isolation of brucellae was hindered by the slow
growth of the organism and the lack of a suitable commercial blood culture system. To improve
recovery of this fastidious bacterium, use of biphasic media, prolonged incubation of vials,
and periodic performance of blind subcultures have been traditionally recommended.
Development of automated blood culture systems in recent decades has resulted in the gradual
increase in sensitivity and shortening of detection time of Brucella species. Nowadays, use of
modern blood culture systems makes possible the diagnosis of more than 95% of positive
cultures within the routine 7-day incubation protocol, and performance of subcultures of
negative media is no longer necessary. Additional advances, especially the development of
MALDI-TOF technology and nucleic acid amplification and hybridization assays, in recent
years, enable a rapid and precise identification of the genus.
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